Pancreatic Ductal Adenocarcinoma
📧 Sign up to get email alerts when something new happens for Pancreatic Ductal Adenocarcinoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2024-12-24Clinical Trial Update: NALIRI-XELOX+AK104 for First-line Treatment of Advanced PDAC [Phase 2]
A Phase 2 clinical trial update evaluating nanoliposomal irinotecan with XELOX plus cadonilimab (AK104) as first-line treatment for advanced…
-
CLINICAL_TRIALS trial_result · 2024-12-13Clinical Trial Update: A Phase I/Ib Study of NZV930 Alone and in Combination With PDR001 and /or NIR178 in Patients With Advanced Malignancies. [Phase 1]
A Phase I/Ib trial of NZV930 alone and in combination with PDR001 and/or NIR178 in patients with advanced malignancies has been terminated.
-
CLINICAL_TRIALS trial_result · 2024-12-10Clinical Trial Update: Combination Therapy for Patients With Untreated Metastatic Pancreatic Ductal Adenocarcinoma [Phase 2]
A Phase 2 trial of a combination therapy for untreated metastatic pancreatic ductal adenocarcinoma has completed and posted results.
-
CLINICAL_TRIALS trial_result · 2024-12-06Clinical Trial Update: Study on Single-cell Regulons Atlas of Pancreatic Ductal Adenocarcinoma
A completed clinical trial investigating a single-cell regulons atlas for pancreatic ductal adenocarcinoma to support a molecular prognostic…
-
CLINICAL_TRIALS trial_result · 2024-11-06Clinical Trial Update: A Dual Channel Supraglottic Airway Device (LMA Gastro) for Oxygenation in Patients Undergoing ERCP [NA]
A completed clinical trial evaluated the LMA Gastro dual-channel supraglottic airway device for oxygenation during ERCP procedures.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2024-10-24Clinical Trial Update: Gemcitabine Hydrochloride With or Without Erlotinib Hydrochloride Followed by the Same Chemotherapy Regimen With or Without Radiation Therapy and Capecitabine or Fluorouracil in Treating Patients With Pancreatic Cancer That Has Been Removed by Surgery [Phase 3]
Phase 3 trial updates evaluate gemcitabine with or without erlotinib followed by the same regimen with or without radiation therapy and cape…
-
CLINICAL_TRIALS trial_result · 2024-10-16Clinical Trial Update: A Combination of AKR1B10 and CA19-9 Improves the Diagnosis of PDAC
A clinical trial update suggests that combining AKR1B10 and CA19-9 improves the diagnosis of pancreatic ductal adenocarcinoma.
-
CLINICAL_TRIALS trial_result · 2024-10-01Clinical Trial Update: Olaparib in Treating Patients With Stage IV Pancreatic Cancer [Phase 2]
This Phase 2 trial evaluated olaparib in patients with Stage IV pancreatic cancer, and results have been posted.
-
CLINICAL_TRIALS trial_result · 2024-09-04Clinical Trial Update: CEND-1 Injection (QLC12102) in Patients With Advanced Metastatic Pancreatic Ductal Adenocarcinoma [Phase 1, Phase 2]
A Phase 1/2 trial of CEND-1 Injection (QLC12102) in advanced metastatic pancreatic ductal adenocarcinoma has completed.
-
CLINICAL_TRIALS trial_result · 2024-08-28Clinical Trial Update: CEND-1 in Combination With Nabpaclitaxel and Gemcitabine in Metastatic Pancreatic Cancer [Phase 1]
This clinical trial update reports the Phase 1 study of CEND-1 in combination with nab-paclitaxel and gemcitabine for metastatic pancreatic …
-
CLINICAL_TRIALS trial_result · 2024-08-23Clinical Trial Update: Transabdominal Ultrasound With BR55 for Characterization of Pancreatic Lesions [Phase 2]
Phase 2 study evaluating transabdominal ultrasound with BR55 to characterize pancreatic lesions in pancreatic ductal adenocarcinoma. The tri…
-
CLINICAL_TRIALS trial_result · 2024-08-22Clinical Trial Update: A First-in-Human Study of CAN04 in Patients With Solid Malignant Tumors [Phase 1, Phase 2]
Cantargia AB's CAN04 first-in-human study in solid malignant tumors (Phase 1/2) has completed. The trial encompassed several indications, in…
-
CLINICAL_TRIALS trial_result · 2024-07-30Clinical Trial Update: A Phase 2 Study of Cediranib in Combination With Olaparib in Advanced Solid Tumors [Phase 2]
A Phase 2 trial evaluating Cediranib in combination with Olaparib in advanced solid tumors has posted results as of 2024-07-30. Indications …
-
CLINICAL_TRIALS trial_result · 2024-06-25Clinical Trial Update: An Evaluation of the Utility of the ExSpiron Respiratory Variation Monitor During Upper GI Endoscopy [NA]
Results from a study evaluating the ExSpiron Respiratory Variation Monitor during upper GI endoscopy have been posted.
-
CLINICAL_TRIALS trial_result · 2024-06-06Clinical Trial Update: Pilot Phase 2 Study to Investigate the Preliminary Efficacy and Safety of INNO-206 in Advanced Pancreatic Cancer [Phase 2]
This update announces the completion and posting of results for a Phase 2 pilot study evaluating INNO-206 in advanced pancreatic ductal aden…
-
CLINICAL_TRIALS trial_result · 2024-05-24Clinical Trial Update: A Study of SLC-0111 and Gemcitabine for Metastatic Pancreatic Ductal Cancer in Subjects Positive for CAIX [Phase 1, Phase 2]
The Phase 1/2 study of SLC-0111 in combination with gemcitabine for CAIX-positive metastatic pancreatic ductal adenocarcinoma has been termi…
-
CLINICAL_TRIALS trial_result · 2024-03-27Clinical Trial Update: Peri-operative SLOG for Localized Pancreatic Cancer [Phase 2]
Phase 2 clinical trial update for peri-operative SLOG in localized pancreatic cancer (pancreatic ductal adenocarcinoma).
-
CLINICAL_TRIALS trial_result · 2024-03-26Clinical Trial Update: KN046 in Subjects With Advanced Pancreatic Ductal Adenocarcinoma. [Phase 3]
Phase 3 clinical trial update for KN046 in advanced pancreatic ductal adenocarcinoma; status not specified.
-
CLINICAL_TRIALS trial_result · 2024-02-14Clinical Trial Update: Perioperative Therapy for Resectable and Borderline-Resectable Pancreatic Adenocarcinoma With Molecular Correlates [Phase 2]
A Phase 2 clinical trial evaluating perioperative therapy for resectable and borderline-resectable pancreatic adenocarcinoma with molecular …
-
CLINICAL_TRIALS trial_result · 2024-01-29Clinical Trial Update: A Phase 1/2, First-in-Human, Open Label, Dose Escalation Study Of A CSP Targeting Functional Antibody in Solid Tumors [Phase 1, Phase 2]
Phase 1/2 first-in-human open-label dose-escalation study of a CSP-targeting functional antibody in solid tumors completed.
-
CLINICAL_TRIALS trial_result · 2024-01-10Clinical Trial Update: Synergistic Immunomodulatory Effect of Synbiotics Pre and Postoperative Resection of Pancreatic Ductal Adenocarcinoma [Phase 4]
A Phase 4 trial evaluating the synergistic immunomodulatory effect of synbiotics administered around surgical resection for pancreatic ducta…
-
CLINICAL_TRIALS trial_result · 2024-01-10Clinical Trial Update: Combined S-1 With DC+CIK As Maintenance Therapy For Advanced Pancreatic Ductal Adenocarcinoma [Phase 2, Phase 3]
Phase 2/3 trial update exploring S-1 combined with DC+CIK as maintenance therapy for advanced pancreatic ductal adenocarcinoma, status curre…
-
CLINICAL_TRIALS trial_result · 2023-12-15Clinical Trial Update: Paclitaxel Protein Bound Plus Cisplatin Plus Gemcitabine and Paricalcitol for Pancreatic Adenocarcinoma (NABPLAGEMD) [Phase 2]
Phase 2 trial of Paclitaxel Protein Bound with cisplatin, gemcitabine, and paricalcitol in pancreatic cancer has completed.
-
CLINICAL_TRIALS trial_result · 2023-12-12Clinical Trial Update: Study to Evaluate the Safety and Activity (Including Distribution) of 177Lu-3BP-227 in Subjects With Solid Tumours Expressing Neurotensin Receptor Type 1. [Phase 1]
Phase 1 trial evaluating safety and activity of 177Lu-3BP-227 in solid tumours expressing neurotensin receptor type 1; study terminated with…
-
CLINICAL_TRIALS trial_result · 2023-11-18Clinical Trial Update: Study of Relacorilant in Combination With Nab-Paclitaxel in Patients With Metastatic Pancreatic Ductal Adenocarcinoma [Phase 3]
Phase 3 trial of relacorilant with nab-paclitaxel in metastatic pancreatic ductal adenocarcinoma was terminated; results posted in 2023.